View of Efficacy and Safety of Imiquimod 5% as Primary Therapy in Management of Nodular Basal Cell Carcinoma of the Eyelid

Return to Article Details Efficacy and Safety of Imiquimod 5% as Primary Therapy in Management of Nodular Basal Cell Carcinoma of the Eyelid Download Download PDF